Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Japan
Japan: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 91.0% in 2024. ▬ Flat
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Japan, 2011–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
In 2024, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Japan stood at 91.0%. That is the lowest value across all 14 years on record.
The figure is down 6.2% on the previous year and down 7.1% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Japan peaked at 99.0% in 2016 and was at its lowest, 91.0%, in 2024.
Japan ranks 52nd of 146 countries on this measure, in the middle of the range.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Japan, year by year
| Year | % | Change |
|---|---|---|
| 2011 | 98.0% | — |
| 2012 | 98.0% | +0.0% |
| 2013 | 98.0% | +0.0% |
| 2014 | 98.0% | +0.0% |
| 2015 | 96.0% | -2.0% |
| 2016 | 99.0% | +3.1% |
| 2017 | 99.0% | +0.0% |
| 2018 | 98.0% | -1.0% |
| 2019 | 97.0% | -1.0% |
| 2020 | 95.0% | -2.1% |
| 2021 | 96.0% | +1.1% |
| 2022 | 97.0% | +1.0% |
| 2023 | 97.0% | +0.0% |
| 2024 | 91.0% | -6.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 97.9% | 96.0% | 99.0% | 9 |
| 2020s | 95.2% | 91.0% | 97.0% | 5 |
Countries ranked near Japan
More health data for Japan
- Un projection of annual infant deaths, annual growth rate -2.73 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2774 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,294 deaths per 1,000 people (2090)
- Number of infants who die before age 1 178 deaths (2100)
- Population ages 0-14, female, annual growth rate -2.14 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0547 units per person (2025)
- Population ages 0-14, male, annual growth rate -2.28 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0576 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Japan?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Japan was 91.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Japan?
- The highest recorded value was 99.0% in 2016.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Japan?
- The lowest recorded value was 91.0% in 2024.
- How does Japan rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Japan ranks 52nd out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Japan?
- Over the last ten years it is down 7.1%. The long-run trend across the full record is flat.
- Where does this Japan data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 14 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.